Attività Correnti Cambiamento Data
Bausch Health Companies USD 7.41B 886M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Novo Nordisk DKK 208.7B 31.38B 2026-06
Novo Nordisk DKK 31.89B 145.42B 2026-06
Pacira USD 10.3B 9.68B 2026-09
Sanofi EUR 33.21B 1.68B 2026-09
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09